FDA OKs drug for pain during sex for postmenopausal women

02/26/2013 | CBS News · Drug Store News

Shionogi's Osphena, or ospemifene, has been approved by the FDA to treat dyspareunia, a condition characterized by pain during sex, in postmenopausal women. The drug gives patients another option for treatment, FDA Office of Drug Evaluation Deputy Director Victoria Kusiak said.

View Full Article in:

CBS News · Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX